ZYME logo

ZYMEZymeworks Inc

$22.97
$0.115
(0.50%)
Today
Closed $22.97
$0.005
(0.02%)
After Hours
Updated: 06:28 PM EDT
EarningsAug 6
Mkt Cap$1.68B
Vol1.34M
55

Bullish Sentiment

How do you feel about ZYME?

News
all
press releases
Zymeworks (ZYME) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates
Zymeworks (ZYME) delivered earnings and revenue surprises of -510.13% and -94.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates
uniQure (QURE) delivered earnings and revenue surprises of +2.86% and -48.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Pictet Asset Management Holding SA Invests $1.97 Million in Zymeworks Inc. $ZYME
Pictet Asset Management Holding SA purchased a new position in shares of Zymeworks Inc. (NASDAQ:ZYME - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing...
MarketBeat
News Placeholder
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Beat Estimates
Vertex (VRTX) delivered earnings and revenue surprises of +5.76% and +0.19%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Kornitzer Capital Management Inc. KS Takes $2.34 Million Position in Zymeworks Inc. $ZYME
Kornitzer Capital Management Inc. KS bought a new stake in Zymeworks Inc. (NASDAQ:ZYME - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and...
MarketBeat
News Placeholder
Zymeworks (ZYME) Projected to Post Earnings on Thursday
Zymeworks (NASDAQ:ZYME) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...
MarketBeat
News Placeholder
Zymeworks (NASDAQ:ZYME) Raised to Strong-Buy at Truist Financial
Truist Financial raised Zymeworks to a "strong-buy" rating in a research report on Monday...
MarketBeat
News Placeholder
Zymeworks (NASDAQ:ZYME) Hits New 52-Week High - Time to Buy?
Zymeworks (NASDAQ:ZYME) Reaches New 12-Month High - Should You Buy...
MarketBeat
News Placeholder
Zymeworks Highlights Royalty-Fueled Pivot at Bloom Burton, Eyes Multibillion-Dollar Ziihera
Zymeworks (NASDAQ:ZYME) used a presentation at the Bloom Burton conference to outline how the company is repositioning itself around its first approved product and a growing stream of royalty and...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.